Latest Leadership News

Arovella Therapeutics has named Dr Nicole Van Der Weerden as acting CEO following Dr Michael Baker’s departure, positioning her to steer the company through the critical phase I trial of its CAR-iNKT therapy ALA-101.

Adavale Resources (ASX:ADD) is intensifying its drilling campaign at the London Victoria gold mine, delivering promising high-grade results and expanding its footprint with new tenure acquisitions. The company targets a mid-year resource update amid ongoing assay releases and greenfield exploration.

Amcor posted a 77% jump in Q3 net sales fueled by the Berry acquisition, delivering synergy gains above expectations and updating fiscal 2026 guidance amid geopolitical headwinds.

BrainChip detailed significant progress in its neuromorphic AI technology and commercial strategy at its 2026 AGM, highlighting the AKD1500 chip launch and expanding defense and industrial collaborations.

Odessa Minerals has raised $2.65 million through a strongly supported placement and appointed Sam Brooks, an experienced geologist, to its board to boost project acquisition efforts.

Ark Mines has intercepted low-grade gold in its Sandy Mitchell Rare Earths Project, revealing potential value-add from gold credits alongside rare earths. Further assays and development studies are underway.

Kingsrose Mining has appointed Andrew Caruso as its new CEO, bringing over three decades of mining leadership experience to drive its Scandinavian projects and acquisition strategy. His remuneration package includes a base salary of CND$400,000 plus performance-linked incentives tied to share price milestones.

Perpetual Limited is sharpening its focus on asset management and corporate trust following the binding agreement to sell its Wealth Management arm to Bain Capital for $500 million upfront, aiming to strengthen its balance sheet and simplify operations.

Acusensus Limited maintains its FY26 revenue and EBITDA guidance while advancing multiple enforcement programs across the US, UK, New Zealand, and Australia, underpinned by new product developments and international growth.

IMDEX Limited has delivered a record 3Q FY26 revenue increase of 29% in constant currency, fueled by strong global demand, strategic acquisitions, and AI-enabled mining technology solutions.

Noxopharm is gearing up for a pivotal pre-IND meeting with the US FDA, enlisting global CRO Novotech to sharpen its regulatory approach for SOF-SKN, a drug targeting autoimmune skin diseases.

Carnavale Resources has appointed Humphrey Hale as Managing Director, entrusting him to lead the Kookynie Gold Project into production as the company nears completion of its bankable feasibility study.